Krystal Biotech (KRYS) Cash from Operations (2016 - 2026)
Krystal Biotech (KRYS) posted Cash from Operations of $91.25 million for Q3 2026, up 130.1% from $39.66 million a year earlier and up 22.0% from the prior quarter.
Powered by 
Analysis
Krystal Biotech (KRYS) Cash from Operations (2016 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Cash from Operations at Krystal Biotech was $323.93 million, up 83.8% year-over-year; for FY2025, it came in at $200.87 million, up 62.7% from FY2024.
- In prior years, Krystal Biotech's Cash from Operations was $123.42 million in FY2024, -$88.8 million in FY2023, -$100.57 million in FY2022 and -$47.94 million in FY2021.
- The Q3 2026 figure stands as the highest quarterly Cash from Operations in data going back to Q4 2016.
- On a year-over-year basis, Cash from Operations has increased in each of the last four quarters, with growth averaging 73.4% over the last six quarters.
- According to Business Quant data, Cash from Operations for the three prior quarters was $74.79 million (Q2 2026), $80.38 million (Q1 2026) and $77.51 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 11.40 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 7.72 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.61 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 6.56 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.67 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.24 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 5.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.38 Bn |
| 10 | Krystal Biotech | 9.08 Bn | 5.67 Bn | 119.79 Mn | 91.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 91.25 Mn |
| Jun 30, 2026 | 74.79 Mn |
| Mar 31, 2026 | 80.38 Mn |
| Dec 31, 2025 | 77.51 Mn |
| Sep 30, 2025 | 39.66 Mn |
| Jun 30, 2025 | 52.73 Mn |
| Mar 31, 2025 | 30.97 Mn |
| Dec 31, 2024 | 52.84 Mn |
| Sep 30, 2024 | 58.86 Mn |
| Jun 30, 2024 | -4.17 Mn |
| Mar 31, 2024 | 15.89 Mn |
| Dec 31, 2023 | -7.23 Mn |
| Sep 30, 2023 | -21.23 Mn |
| Jun 30, 2023 | -34.19 Mn |
| Mar 31, 2023 | -26.16 Mn |
| Dec 31, 2022 | -22.33 Mn |
| Sep 30, 2022 | -19.69 Mn |
| Jun 30, 2022 | -43.06 Mn |
| Mar 31, 2022 | -15.49 Mn |
| Dec 31, 2021 | -20.90 Mn |
API Access
Krystal Biotech Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=KRYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "KRYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=KRYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();